Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 14
Phase 21

Trial Status

Completed3
Terminated1

Role Distribution

Principal Investigator2
Other Roles2
PI Rate50%

Activity Timeline

Clinical Trials (4)

NCT00072410Phase 1Completed
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer
Ovarian Cancer
PrincipalinvestigatorStart date: 2003-11-01
NCT00003102Phase 1/2Completed
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
Kidney Cancer
StudychairStart date: 1998-11-17

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Moderately Similar
32 trials

Shared therapeutic areas:

Ovary CancerLung CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Moderately Similar
26 trials

Shared therapeutic areas:

Lung CancerCancer of KidneyOvary Cancer
Similarity Score30%

Robert J. Motzer, MD

Memorial Sloan Kettering Cancer Center

Moderately Similar
16 trials

Shared therapeutic areas:

Cancer of KidneyOvary CancerLung Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Lung CancerOvary Cancer
Similarity Score20%

Steven A. Rosenberg, MD, PhD

NCI - Surgery Branch

Related
29 trials

Shared therapeutic areas:

Cancer of KidneyOvary Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Lung CancerOvary Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Lung CancerOvary Cancer
Similarity Score20%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Lung CancerOvary Cancer
Similarity Score20%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Ovary CancerCancer of Kidney

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score20%

Lee M. Krug, MD

Memorial Sloan Kettering Cancer Center

Related
7 trials

Shared therapeutic areas:

Lung Cancer

Worked with same sponsors:

Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00084799Phase 1PrincipalInvestigator

Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer (SCLC)

Lung Cancer
Completed
NCT00072410Phase 1PrincipalInvestigator

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

Ovarian Cancer
Completed
NCT00006099Phase 1StudyChair

Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer

Ovarian Cancer
Terminated
NCT00003102Phase 1/2StudyChair

Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer

Kidney Cancer
Completed

All 4 trials loaded